| A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy AS Gaifullina, J Lazniewska, EV Gerasimova, GF Burkhanova, ... Pain 160 (12), 2798-2810, 2019 | 30 | 2019 |
| Trigeminal neuropathic pain is alleviated by inhibition of Cav3.3 T-type calcium channels in mice M Montera, A Goins, L Cmarko, N Weiss, KN Westlund, SRA Alles Channels 15 (1), 31-37, 2021 | 21 | 2021 |
| Functional identification of potential non-canonical N-glycosylation sites within Cav3.2 T-type calcium channels V Ficelova, IA Souza, L Cmarko, MA Gandini, RN Stringer, GW Zamponi, ... Molecular brain 13, 1-4, 2020 | 11 | 2020 |
| Identification of a molecular gating determinant within the carboxy terminal region of Cav3.3 T-type channels B Jurkovicova-Tarabova, L Cmarko, R Rehak, GW Zamponi, L Lacinova, ... Molecular brain 12, 1-11, 2019 | 11 | 2019 |
| Selective inhibition of neuronal Cav3.3 T-type calcium channels by TAT-based channel peptide L Cmarko, N Weiss Molecular brain 13 (1), 95, 2020 | 5 | 2020 |
| Secretory carrier-associated membrane protein 2 (SCAMP2) regulates cell surface expression of T-type calcium channels L Cmarko, RN Stringer, B Jurkovicova-Tarabova, T Vacik, L Lacinova, ... Molecular Brain 15 (1), 1, 2022 | 4 | 2022 |
| Screening an In-House Isoquinoline Alkaloids Library for New Blockers of Voltage-Gated Na+ Channels Using Voltage Sensor Fluorescent Probes: Hits and Biases Q Coquerel, C Legendre, J Frangieh, SD Waard, J Montnach, L Cmarko, ... Molecules 27 (13), 4133, 2022 | 2 | 2022 |
| Electrophysiological characterization of a Cav3.2 calcium channel missense variant associated with epilepsy and hearing loss RN Stringer, L Cmarko, GW Zamponi, M De Waard, N Weiss Molecular Brain 16 (1), 68, 2023 | 1 | 2023 |
| Gating properties of Cav3. 3 T-type channel are modulated by highly conserved proximal region in channel carboxy terminus JB Tarabova, L Cmarko, R Rehak, GW Zamponi, L Lacinova, N Weiss ACTA PHYSIOLOGICA 227, 86-86, 2019 | | 2019 |
| Abstract: Voltage-gated Na+(Na V) channels are significant therapeutic targets for the treatment of cardiac and neurological disorders, thus promoting the search for novel Na V … Q Coquerel, C Legendre, J Frangieh, SD Waard, J Montnach, L Cmarko, ... These five alkaloids were then assayed using the Na+ fluorescent probe ANG-2 …, 0 | | |
